Research Article
Valsartan in Combination with Tripterygium Glycosides Protects against Chronic Nephritis via the Toll-Like Receptor 4 Pathway
Table 2
Baseline data of the two groups.
| | Control group () | Observation group () | |
| | Gender | | | 0.178 | | Male ( (%)) | 35 (31.82%) | 27 (24.55%) | | | Female ( (%)) | 20 (18.18%) | 28 (25.45%) | | | Age (years) | | | 0.270 | | Course of disease (years) | | | 0.107 | | Basic diseases | | | 0.625 | | Diabetes ( (%)) | 3 (2.73%) | 4 (3.64%) | | | Hypertension ( (%)) | 5 (4.55%) | 7 (6.36%) | | | Hyperlipemia ( (%)) | 5 (4.55%) | 3 (2.73%) | |
|
|
